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Abstract
Calmodulin (CaM) acts as a primary mediator of calcium signaling by interacting with target proteins. We have previously
shown that nuclear CaM is critical for cell cycle progression using a transgene containing four repeats of a CaM inhibitor
peptide and nuclear targeting signals (J. Wang et al., J. Biol. Chem. 270 (1995) 30245^30248; Biochim. Biophys. Acta 1313
(1996) 223^228). To evaluate the role of CaM in the nucleus specifically during S phase of the cell cycle, a motif which
stabilizes the mRNA only during S phase was included in the transgene. The CaM inhibitor mRNA transcript contains a self-
annealing stem-loop derived from histone H2B at the 3P end. This structure provides stability of the mRNA only during S
phase, thereby restricting CaM inhibitor expression to S phase. The inhibitor accumulates in the nucleus, particularly in the
nucleoli. Flow cytometric analysis demonstrated that the CaM inhibitor is expressed in S and G2. Transfected cells show
growth inhibition and a reduction in DNA synthesis. The CaM inhibitor peptide is a versatile reagent that allows spatial as
well as temporal dissection of calmodulin function. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
Extracellular calcium is required for cell viability
and proliferation. Calmodulin, a ubiquitous Ca2-
binding protein, is a primary regulator of Ca2-de-
pendent proliferation in mammalian cells. An in-
crease in the level of CaM accelerates the rate of
cell proliferation, whereas a reduction leads to cessa-
tion of proliferation [3,4]. The calmodulin antago-
nists, W7 and W13, inhibit DNA synthesis [5^7],
blocking cell cycle progression at the G1/S boundary,
and during G2/M. Antibodies against CaM have
been shown to inhibit DNA synthesis in permeabi-
lized cells [8]. Calmodulin transduces the calcium sig-
nal through direct interactions with its target pro-
teins. CaM has been implicated in the control of
many cell cycle events such as gene expression,
DNA synthesis, and nuclear envelope breakdown
by interacting with proteins such as CaM dependent
kinases and phosphatases associated with the nu-
cleus. These observations suggest that CaM may be
an essential component of the cell cycle machinery.
Interpretation of these results, however, is hampered
by the fact that these drugs also interact with other
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proteins in addition to CaM [9] and the data re£ect
global cellular changes in CaM function.
We have developed a strategy to evaluate the role
of nuclear CaM that is independent from that of
cytoplasmic CaM [1]. This approach uses a potent,
nuclear targeted calmodulin inhibitor peptide. This
peptide inhibits Ca2/CaM dependent protein kinase
II in a concentration-dependent manner and blocks
cell cycle progression when expressed in Cos-7 cells
[1,2]. To limit expression of this peptide to a speci¢c
stage of the cell cycle, the histone stem-loop sequence
was included to be transcribed at the 3P untranslated
region of the mRNA. This motif stabilizes histone
mRNA only during S phase of the cell cycle [10].
In the present study this CaM inhibitor peptide
was evaluated with regard to cellular targeting, tem-
poral expression, and cell cycle progression.
2. Materials and methods
2.1. Calmodulin inhibitor peptide transgenes
The calmodulin inhibitor transgene, CaMBP4-SL,
was used to evaluate nuclear calmodulin function in
HeLa and Cos-7 cells. The calmodulin-binding re-
gion of rabbit skeletal muscle myosin light chain kin-
ase (skMLCK) was selected to be expressed as a
speci¢c CaM inhibitor (Fig. 1C) [1,2]. The CaM-
binding peptide was constructed as a tandem repeat
containing several nuclear targeting signals to direct
the peptide to the nucleus. The histone stem-loop
was added following the stop codon to stabilize
mRNA only during S phase of the cell cycle.
2.2. Cell culture and immunostaining
HeLa and Cos-7 cells were maintained in Dulbec-
co’s modi¢ed Eagle’s medium (Life Technologies)
containing 10% fetal bovine serum at 37‡C in a 5%
CO2 incubator. The mammalian expression vector,
CaMBP4-SL, was transiently transfected into HeLa
cells using either Superfect reagent or Lipofectamine
(Gibco BRL) following the manufacturer’s instruc-
tions. At 24 h after transfection, cells on coverslips
were prepared for labeling with antibody. Cells were
¢xed in formalin for 15 min at room temperature
and permeabilized with acetone for 7 min at
320‡C. To visualize transgenic peptide expression,
cells were incubated with rabbit anti-CaMBP anti-
body for 2 h, washed in phosphate-bu¡ered saline
(PBS), and treated with Cy3-conjugated goat anti-
rabbit IgG. The coverslips were then mounted and
photographed using Kodak Elite 200 Ektachrome
¢lm with a Nikon Micro£ex UFX exposure attach-
ment mounted on a Nikon Optiphot epi£uorescence
microscope with the appropriate Nikon £uorescence
¢lter cubes.
In double-immunolabeling experiments, monoclo-
nal anti-cyclin B (Transduction Laboratories) was
visualized with FITC-conjugated goat anti-mouse
IgG. Monoclonal anti-Ki-67 (Boehringer Mannheim)
was visualized with FITC conjugated goat anti-
mouse IgG.
2.3. Isolation of nuclear calmodulin-binding proteins,
antibody preparation, and the e¡ect of growth
arrest on intracellular localization
Nuclei were prepared by sucrose density gradient
fractionation of homogenized livers harvested from
rats treated with thioacetamide to increase nucleolar
activity. Nuclei were sonicated and soluble proteins
were applied to calmodulin^Sepharose [11]. Anti-cal-
plasin antibodies were puri¢ed by a⁄nity chromatog-
raphy against nuclear calmodulin-binding proteins
that had been fractionated by gel ¢ltration on ultro-
gel AcA34.
2.4. BrdU labeling
BrdU labeling to assess DNA synthesis was per-
formed on Cos-7 cells. These cells were maintained in
Dulbecco’s modi¢ed Eagle’s medium (Life Technol-
ogies) containing 10% fetal bovine serum at 37‡C in
a 5% CO2 incubator. CaMBP4-SL was transiently
transfected into Cos-7 cells using a modi¢ed calcium
precipitation method [2]. Transfected cells were
grown on 22U22-mm coverslips for 47 h after trans-
fection. Cells were then incubated with 5-bromo-2P-
deoxyuridine (BrdU) labeling medium with the ¢nal
concentration of 10 Wmol/l BrdU (Boehringer Mann-
heim) for 1 h. Cells were then washed in PBS and
¢xed in 70% ethanol (in 50 mmol/l glycine bu¡er, pH
2.0) for 20 min at 320‡C. Fixed cells ere incubated
with monoclonal anti-BrdU antibody at 37‡C for
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30 min, washed, and treated with £uorescein-conju-
gated sheep anti-mouse IgG. Cells were then immu-
nostained with a⁄nity puri¢ed rabbit anti-CaMBP
peptide antibody [1] and visualized with Cy3-conju-
gated goat anti-rabbit IgG (Jackson Laboratories).
2.5. Flow cytometry
HeLa cells were trypsinized, washed twice with
PBS, and ¢xed in formalin for 30 min on ice. Cells
were washed in PBS and permeabilized with 0.05%
saponin for 15 s. Following permeabilization, cells
were treated with 5 Wg/ml RNaseA and blocked in
10% goat serum. Cells were immunostained with rab-
bit anti-CaMBP antibody visualized with FITC-con-
jugated goat anti-rabbit IgG, then labeled with pro-
pidium iodide (10 Wg/ml), and analyzed by £ow
cytometry. Ten thousand cells were examined for
each sample using a Coulter EPICS XL (Miami,
FL) and the cells were excited using a 488 nm argon
laser. Fluorescence emissions of 525 nm and 610 nm
were collected. Cell cycle analysis was performed us-
ing Multicycle software.
2.6. MTT assay
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-di-
phenyl tetrazolium bromide) assay was used to assess
cell growth and viability in control and transfected
cells through the formation of a formazan product.
Cos-7 cells were plated in 96-well plates (1000 cells/
well) and cell viability was measured at 24, 48, and
72 h. At each time point, 25 Wl of MTT (5 mg/ml in
PBS) was added to each well. Following a 2-h incu-
bation at 37‡C, 100 Wl of extraction bu¡er (50% di-
methylformamide, 10% sodium dodecyl sulfate, pH
4.7) was added to each well and incubated overnight
at 37‡C. The absorbance was read at 570 nm using
the MR580 Microelisa Auto Reader (Dynatech).
Twenty wells were read for each sample at each
time point.
3. Results and discussion
In order to analyze the function of calmodulin in
the nucleus during S phase of the cell cycle, we con-
structed a calmodulin inhibitor peptide transgene,
CaMBP4-SL, that contained the histone stem-loop
sequence following the stop codon. The 3P stem-
loop at the end of histone mRNA is responsible
for the 35-fold increase in mRNA levels between
G1 and S phase and also for the 35-fold decrease
in mRNA levels between S and M phases [10] (Fig.
1A). The addition of the histone stem-loop to the
calmodulin inhibitor mRNA should restrict expres-
sion of the inhibitor to S phase (Fig. 1B).
Fig. 1. Design of the calmodulin inhibitor peptide gene. (A)
The histone stem loop is responsible for the 35-fold increase of
histone mRNA during S phase and the 35-fold decrease in
mRNA after S phase. (B) The mRNA product of the calmodu-
lin inhibitor gene. The histone stem loop was added to the 3P
untranslated region of the calmodulin gene. Note the four re-
peats of the calmodulin-binding peptide which inhibits calmod-
ulin function. (C) The calmodulin-binding region of rabbit
skeletal muscle myosin light chain kinase is tandemly repeated
in the inhibitor gene. The repeats of the calmodulin-binding
peptide create several nuclear localization signals (KRR-KK-
KK), targeting the inhibitor to the nucleus.
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Fig. 2. Analysis of CaMBP4-SL expression in HeLa cells. Phase contrast image (A) and immuno£uorescence image (B) of cells were
harvested 24 h after transient transfection and were immunostained with anti-CaMBP antibody followed by Cy3-conjugated goat anti-
rabbit (red). Note that the peptide accumulates in the nucleus and is absent in the cytoplasm. (C,D) Cells were transfected and incu-
bated 24 h. Cells were then stained with anti-CaMBP antibody and FITC-conjugated goat anti-rabbit IgG. CaMBP accumulates in
spheres located in the nucleus (C) and transfected cells often contain multi-lobed nuclei (D).
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To evaluate targeting of the peptide, HeLa cells
were transiently transfected with the CaMBP4-SL
transgene. Cells were examined by phase contrast
and indirect immuno£uorescence using a⁄nity-puri-
¢ed antibody produced against the inhibitor peptide
(Fig. 2A,B). The peptide accumulated in multiple
spheres, approximately 0.1 to 0.5 Wm, in the nucleus
(Fig. 2C). The nuclei became large and multi-lobed
and often appeared fragmented, indicating disruption
of nuclear structure (Fig. 2D). To examine the spa-
tial relationship of CaMBP with nuclear proteins,
transfected HeLa cells were double-immunolabeled
with anti-CaMBP antibody (Fig. 3A) and anti-Ki-
67, an antibody that recognizes an antigen (Ki-67)
in the nucleoli (Fig. 3B) [12^14]. The anti Ki-67
staining pattern was doughnut-like, and co-localized
with anti-CaMBP antibody indicating that the
CaMBP transgene product is present in both the nu-
cleoplasm and at high concentrations in the nucleo-
lus. Calmodulin and the calmodulin-dependent en-
zymes, calplasin (Fig. 4), myosin light chain kinase
and CaMKII, have also been found in high concen-
trations in nucleoli [15^19]. Evaluation of this trans-
gene product will reveal the regulatory role of CaM
in ribosome production and assembly and the poten-
tial e¡ects on protein synthesis.
To assess the ‘timing’ of CaMBP4-SL expression,
we examined CaMBP expression versus DNA con-
tent by £ow cytometry. DNA content was judged by
propidium iodide (PI) staining and peptide expres-
sion by antibody labeling using an FITC conjugated
secondary antibody. Flow cytometric analysis of
DNA content and light scattering properties of con-
trol cells showed a normal DNA content pro¢le and
a single population of cells on a forward scatter ver-
sus side scatter dot plot (data not shown). Fig. 5
shows cell cycle pro¢les for control (A) and trans-
fected cells (B). Cells which stained positive for
CaMBP were analyzed for cell cycle progression.
Transfected cells were mainly in S and G2/M phases
of the cell cycle (Fig. 5B). PI staining cannot distin-
guish between G2 and M phases; however, when
Fig. 3. Co-localization of CaMBP4 and Ki-67, a nucleolar antigen. Twenty-four hours after transfection, cells were harvested and dou-
ble-immunostained with anti-CaMBP antibody followed by Cy3-conjugated goat anti-rabbit (A) and anti-Ki-67 antibody visualized by
£uorescein-conjugated goat anti-mouse IgG (B). Arrows indicate regions were antigens are co-localized.
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Fig. 4. Immunolocalization of calplasin, a nucleolar calmodulin-binding peptide. Normal rat kidney (NRK) cells in log phase of
growth were immunostained with rabbit anti-calplasin antibody, followed by FITC-conjugated goat anti-rabbit antibody.
Fig. 5. CaMBP4-SL expression during cell cycle progression. Twenty-four hours after transfection, cells were harvested for £ow cyto-
metry and labeled with PI to measure DNA content and anti-CaMBP antibody visualized with FITC-conjugated goat anti-rabbit IgG.
Cells that showed about background levels of £uorescein staining were analyzed for their distribution in the cell cycle. Note that cells
expressing CaMBP were restricted to S and G2 phases of the cell cycle.
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Fig. 6. (A) MTT assay of transfected and control cells shows a reduction in cell viability and growth for transfected cell versus con-
trol cells. (B) Analysis of BrdU incorporation in Cos-7 cells transfected with the CaMBP4-SL gene. Cells were double-immunostained
with a⁄nity-puri¢ed anti-CaM-binding peptide antibody, followed by Cy3-conjugated goat anti-rabbit IgG and anti-BrdU antibody
visualized with £uorescein-conjugated goat anti-mouse IgG. The red cell is transfected and not incorporating BrdU; the green cell is
untransfected and incorporating BrdU; the yellow cell (arrow) is both transfected and incorporating BrdU.
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examined by light microscopy, all transfected cells
observed contained a nuclear membrane and there-
fore we not in M phase. Thus, addition of the stem-
loop to the inhibitor peptide mRNA limited expres-
sion of the peptide to S and G2 phases of the cell
cycle.
To analyze the e¡ects of S and G2 phase expres-
sion of the CaM inhibitor on cell growth, we used
the MTT assay. Cell growth was assessed by the
mitochondrial dependent production of a formazan
product that could be quantitated spectrophotomet-
rically. In the control cell population, absorbance at
570 nm increased from 0.25 to 0.51 within 72 h (Fig.
6A). However, in the population of cells that had
been transfected, this increase in absorbance was
substantially reduced; the cell population absorbance
increased from 0.22 to 0.24 within 72 h, indicating a
reduction in cell growth and viability in cells express-
ing CaMBP4.
Calmodulin inhibition during S and G2 phase of
the cell cycle could inhibit cell growth through sev-
eral pathways. Inhibition of DNA synthesis may re-
sult from expression of the inhibitor peptide. Incor-
poration of BrdU, a thymidine analog, into DNA
was used as an indicator of DNA synthesis. Cos-7
cells were transfected with CaMBP4-SL. After 47 h,
cells were pulsed with BrdU for 1 h, ¢xed and im-
munostained with anti-BrdU antibody and anti-
CaMBP antibody. Approximately 50% of the cells
expressing CaMBP4 did incorporate some of the
BrdU, indicating that DNA synthesis was not com-
pletely inhibited by this transgene (Fig. 5B).
It is likely that the CaMBP4 must reach a thresh-
old level before all nuclear calmodulin activity is ab-
lated. The rate at which CaMBP4-SL reaches this
threshold will depend on (1) the number of copies
of plasmid transfected into the cell, and (2) during
which phase of the cell cycle transfection takes place.
If, for example, cells in G1 are transfected, CaMBP4-
SL should accumulate to above threshold levels,
block cells in S phase, and inhibit DNA synthesis.
However, if cells are in late S phase when trans-
fected, then CaMBP may not accumulate to the nec-
essary level to arrest cells in S phase. Cells will in-
corporate BrdU and enter G2. We are currently
generating stable cell lines containing the CaMBP-
SL construct containing an inducible promoter to
circumvent these problems.
The expression of CaMBP4-SL is restricted to S
and G2 phases of the cell cycle and cells expressing
this calmodulin inhibitor show a decrease in cell
growth. This reduction in cell growth is due, in
part, to inhibition of DNA synthesis. Additionally,
because CaMBP is enriched in the nucleoli, growth
inhibition may be due to a reduction in ribosome
production and an accompanying decrease in protein
synthesis. Pursuit of the role of CaM in nuclear
events leading from the initial stimulus to cell pro-
liferation will require analysis of the individual CaM
target proteins present in the nucleus. The inhibitor
peptide strategy is a versatile approach that can be
used to spatially and temporally dissect signaling
pathways in the cell.
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